Development and optimization of an enantiosselective method for the analysis of nebivolol by capillary electrophoresis (#278)
Nebivolol is an antihypertensive drug,
adrenergic β1 block which is commercialized in the racemic form as RSSS and
SRRR-nebivolol. These both enantiomers have distinct pharmacological
properties, which suggests a different pharmacokinetic for each one. Therefore,
a method to the enantiosselective analysis of nebivolol by capillary
electrophoresis was developed and optimized using a derivatized cyclodextrin
(Carboxymethyl-β-cyclodextrin – CM-β-CD) as chiral selector. Many parameters were
evaluated, such as cyclodextrin and buffer concentration, pH, temperature and
voltage applied, in order to optimize the resolution and analysis time. The analyses
were performed in a Capillary Electrophoresis system (Beckman Counter - P/ACE™
MDQ) equipped with a DAD operating on the wavelength of 280 nm. After the
evaluation of the analytical conditions, it was possible to select the most
adequate ones to the resolution of nebivolol enantiomers, which were an
electrolyte solution composed by Sodium Acetate buffer 50 mmol L-1, pH 4.0, CM-β-CD
12.5 mmol L-1 and 1% Acetonitrile at 25° C, applied voltage of 25 kV and a 50
µm i.d and 38.0 cm to the detector length capillary. The resolution under these
conditions was 1.27 and the migration times for RSSS e SRRR- nebivolol, respectively,
were 7.65 and 7.73 min.